Search Results

Nefazodone Hydrochloride 1 g  | ≥98%

LKT Laboratories, Inc.

5-HT2 antagonist, SERT and NET inhibitor, hERG K+ channel blocker.

More Information Supplier Page

×

Nefazodone Hydrochloride

3-Formylrifamycin 5 g  | ≥98%

LKT Laboratories, Inc.

Rifamycin derivative, induces pore formation in mitochondrial membranes; DNA-dependent RNA polymerase inhibitor.

More Information Supplier Page

×

3-Formylrifamycin

3-Formylrifamycin 500 mg  | ≥95%

LKT Laboratories, Inc.

Rifamycin derivative, induces pore formation in mitochondrial membranes; DNA-dependent RNA polymerase inhibitor.

More Information Supplier Page

×

3-Formylrifamycin

Rifamycin SV Monosodium 5 g  | ≥98%

LKT Laboratories, Inc.

Ansamycin; bacterial DNA-dependent RNA polymerase inhibitor, RNA synthesis inhibitor.

More Information Supplier Page

×

Rifamycin SV Monosodium

Rifamycin SV Monosodium 1 g  | ≥98%

LKT Laboratories, Inc.

Ansamycin; bacterial DNA-dependent RNA polymerase inhibitor, RNA synthesis inhibitor.

More Information Supplier Page

×

Rifamycin SV Monosodium

Rimantadine Hydrochloride 50 mg  | ≥98%

LKT Laboratories, Inc.

Viral M2 proton channel blocker.

More Information Supplier Page

×

Rimantadine Hydrochloride

2-(1,8-Naphthyridin-2-ly)phenol 5 g  | ≥98%

LKT Laboratories, Inc.

Naphthalene; indirect STAT1 agonist.

More Information Supplier Page

×

2-(1,8-Naphthyridin-2-ly)phenol

2-(1,8-Naphthyridin-2-ly)phenol 1 g  | ≥98%

LKT Laboratories, Inc.

Naphthalene; indirect STAT1 agonist.

More Information Supplier Page

×

2-(1,8-Naphthyridin-2-ly)phenol

2-(1,8-Naphthyridin-2-ly)phenol 500 mg  | ≥98%

LKT Laboratories, Inc.

Naphthalene; indirect STAT1 agonist.

More Information Supplier Page

×

2-(1,8-Naphthyridin-2-ly)phenol

β-Naphthoflavone 5 g  | ≥98%

LKT Laboratories, Inc.

AhR agonist.

More Information Supplier Page

×

β-Naphthoflavone